XML 22 R7.htm IDEA: XBRL DOCUMENT v3.24.3
Consolidated Statements of Cash Flows - USD ($)
$ in Millions
12 Months Ended
Oct. 31, 2024
Oct. 31, 2023
Oct. 31, 2022
Cash flows from operating activities:      
Net earnings $ 2,775 $ 3,263 $ 3,132
Adjustments to reconcile net earnings to net cash provided by operating activities:      
Depreciation and amortization 830 850 780
Stock-based compensation expense 452 438 343
Restructuring and other charges 301 527 218
Deferred taxes on earnings (122) (923) 577
Other, net (38) (10) 475
Changes in operating assets and liabilities, net of acquisitions:      
Accounts receivable (929) 278 1,285
Inventory (852) 668 214
Accounts payable 2,840 (1,240) (909)
Net investment in leases from integrated financing (165) (110) (155)
Taxes on earnings (24) 198 (134)
Restructuring and other (264) (310) (245)
Other assets and liabilities (1,055) (58) (1,118)
Net cash provided by operating activities 3,749 3,571 4,463
Cash flows from investing activities:      
Investment in property, plant and equipment, net (592) (593) (765)
Purchases of available-for-sale securities and other investments (4) (11) (52)
Maturities and sales of available-for-sale securities and other investments 8 21 9
Collateral posted for derivative instruments 0 0 14
Payments made in connection with business acquisitions, net of cash acquired (58) (7) (2,755)
Net cash used in investing activities (646) (590) (3,549)
Cash flows from financing activities:      
Payments of short-term borrowings with original maturities less than 90 days, net 0 (10) (400)
Proceeds from debt, net of issuance costs 380 255 4,175
Payment of debt and other associated costs (213) (1,700) (693)
Stock-based award activities and others (74) (99) (95)
Repurchase of common stock (2,100) (100) (4,297)
Cash dividends paid (1,075) (1,037) (1,037)
Collateral (returned) withdrawn for derivative instruments 0 (200)  
Collateral (returned) withdrawn for derivative instruments     200
Settlement of cash flow hedges 0 (3)  
Settlement of cash flow hedges     79
Net cash used in financing activities (3,082) (2,894) (2,068)
Increase (decrease) in cash, cash equivalents and restricted cash 21 87 (1,154)
Cash, cash equivalents and restricted cash at beginning of period 3,232 3,145 4,299
Cash, cash equivalents and restricted cash at end of period 3,253 3,232 3,145
Supplemental cash flow disclosures:      
Income taxes paid, net of refunds 649 398 749
Interest expense paid $ 441 $ 548 $ 305